Rennova Health, Inc.
RNVA · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $3,283 | $10 | $0 | $0 |
| - Cash | $49 | $499 | $725 | $25 |
| + Debt | $11,776 | $15,109 | $16,059 | $22,021 |
| Enterprise Value | $15,010 | $14,619 | $15,334 | $21,996 |
| Revenue | $18,686 | $13,036 | $3,224 | $7,200 |
| % Growth | 43.3% | 304.4% | -55.2% | – |
| Gross Profit | $11,111 | $6,268 | -$2,069 | -$4,583 |
| % Margin | 59.5% | 48.1% | -64.2% | -63.7% |
| EBITDA | $1,449 | -$310 | -$1,263 | -$8,410 |
| % Margin | 7.8% | -2.4% | -39.2% | -116.8% |
| Net Income | -$7,729 | -$3,293 | $5,605 | -$18,340 |
| % Margin | -41.4% | -25.3% | 173.9% | -254.7% |
| EPS Diluted | -0 | -0.033 | -913.37 | -93,864,830.67 |
| % Growth | 99.4% | 100% | 100% | – |
| Operating Cash Flow | $3,388 | -$218 | -$8,913 | -$16,928 |
| Capital Expenditures | -$351 | -$35 | $0 | -$371 |
| Free Cash Flow | $3,037 | -$254 | -$8,913 | -$17,299 |